Coherus BioSciences, Inc. (CHRS): A Bull Case Theory

We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on CHRS. Coherus BioSciences, Inc. (CHRS)'s share was trading at $1.11 as of Feb 11^th.

[caption id="attachment_1221536" align="aligncenter" width="768"] A scientist holding a vial of the cancer-fighting drug developed by the biotechnology company.[/caption]

Coherus BioSciences (CHRS) is currently facing a pivotal moment, shifting from a potentially undervalued turnaround opportunity to a more complex situation with both turnaround...